Evaxion Posts Three-Year Data for Personalized Melanoma Vaccine EVX-01
Evaxion Biotech reports three-year follow-up data for EVX-01, its AI-designed personalized therapeutic vaccine for melanoma, extending durability evidence.
Section
Therapeutics & Pipeline
Drug approvals, trial readouts and treatment guidelines.
Final Melanoma Survival Data Headed to ESMO, Faron Confirms
Faron will present final melanoma survival data at the ESMO congress — a mature dataset that could shape advanced cutaneous melan…
Nemolizumab in Children Under 12: The Open Eczema Question
A new report asks whether nemolizumab, the IL-31-targeting biologic, can fill the treatment gap for children under 12 with modera…
Indian Dermatology Online Journal Publishes Comprehensive Abrocitinib Review
A comprehensive abrocitinib review in the Indian Dermatology Online Journal is now indexed on Ovid, widening access for dermatolo…
Topical Febuxostat Quiets Psoriasis in Mouse Model, Bioengineer Reports
A gout pill reformulated as a skin rub cleared psoriasis-linked inflammation in mice, per Bioengineer.org. The xanthine oxidase i…
Non-Steroidal Psoriasis Therapy Reports Symptom Reduction
A Drug Target Review brief reports a promising psoriasis therapy reducing symptoms without corticosteroids, but names no drug, no…
First Human Data on Experimental Eczema Therapy Set for November
First-in-human data on an experimental eczema treatment arrives in November — from healthy volunteers, meaning safety, not effica…
Tildrakizumab Holds Its Effect for 52 Weeks in Japanese Psoriasis Patients
Tildrakizumab sustained its benefit over 52 weeks in Japanese psoriasis patients in real-world care, adding durability evidence f…
JAAD Review Flags Kaposi Sarcoma as Emerging JAK Inhibitor Signal
A JAAD systematic review published online October 17, 2026 consolidates case reports of Kaposi sarcoma emerging during Janus kina…
Topical Roflumilast Rewrites the Safety Story by Route
Topical roflumilast shows how route of administration can rewrite a PDE4 inhibitor's safety profile, concentrating action in skin…